Oncogenetic Studies

11/08/2023

Oncogenetics studies the role of genetic factors in the etiology and pathogenesis of tumours by studying the nucleotide sequence and the mutations that occur in it.

Identifying these mutations makes it possible to improve the effectiveness of treatment, as certain classes of medicines sometimes fail to inhibit the proliferation of certain tumour cells.

Genetic analysis allows targeted drug selection based on the individual mutation, making treatment more effective and personalised.

Oncogenetic studies make it possible to identify the genetic causes of diseases such as colorectal, prostate, breast, ovarian and endometrial cancers.

Lifestyle changes and regular check-ups can not only diagnose various types of oncological diseases in time, prevent complications and provide effective treatment, but in some cases can also prevent the development of the disease.

At the Molecular Diagnostics and Oncogenetics Department of Todua Clinic, it is possible to test for human papillomavirus using the polymerase chain reaction (PCR) method.

Human papillomavirus (HPV) is an infectious agent that is mainly transmitted through sexual contact. Men and women are equally likely to be infected with the virus.

Infection with the papillomavirus is notable because it often causes several types of cancer, including cancers of the vagina, vulva, cervix, penis, colon and throat.

There are more than 100 known types of papillomavirus, some of which have a particularly high oncogenic risk.

Papillomaviruses of a low oncogenic risk can cause visible genital warts.

Although they are not considered to be malignant tumor-causing agents, they cause discomfort and affect the quality of life.